Home/Filings/4/0001209191-20-025305
4//SEC Filing

Evanson Jeff 4

Accession 0001209191-20-025305

CIK 0001649989other

Filed

Apr 20, 8:00 PM ET

Accepted

Apr 21, 6:41 PM ET

Size

4.9 KB

Accession

0001209191-20-025305

Insider Transaction Report

Form 4
Period: 2020-03-19
Evanson Jeff
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2020-03-19+1,207,4571,207,457 total
Footnotes (1)
  • [F1]These shares were issued to the Reporting Person pursuant to the terms of that certain Consulting Agreement dated January 27, 2020, and are subject to repurchase by the Issuer as provided therein.

Issuer

Outlook Therapeutics, Inc.

CIK 0001649989

Entity typeother

Related Parties

1
  • filerCIK 0001760511

Filing Metadata

Form type
4
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 6:41 PM ET
Size
4.9 KB